19972019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mariangela Allocca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Biosimilars of adalimumab: the upcoming challenge in IBD

Fiorino, G., Gilardi, D., Correale, C., Furfaro, F., Roda, G., Loy, L., Argollo, M., Allocca, M., Peyrin-Biroulet, L. & Danese, S., Oct 2019, In : Expert Opinion on Biological Therapy. 19, 10, p. 1023-1030 8 p.

Research output: Contribution to journalArticle

  • Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?

    Argollo, M., Fiorino, G., Gilardi, D., Furfaro, F., Roda, G., Loy, L., Allocca, M., Peyrin-Biroulet, L. & Danese, S., 2019, In : Current Pharmaceutical Design. 25, 1, p. 7-12 6 p.

    Research output: Contribution to journalReview article

  • Detection and management of early stage inflammatory bowel disease: an update for clinicians

    Loy, L., Roda, G., Fiorino, G., Allocca, M., Furfaro, F., Argollo, M., Peyrin-Biroulet, L. & Danese, S., Jun 2019, In : Expert Review of Gastroenterology and Hepatology. 13, 6, p. 547-555 9 p.

    Research output: Contribution to journalReview article

  • Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?

    Argollo, M. C., Allocca, M., Furfaro, F., Peyrin-Biroulet, L. & Danese, S., 2019, In : Current Pharmaceutical Design. 25, 1, p. 25-31 7 p.

    Research output: Contribution to journalReview article